Kevin Strang

Stock Analyst at Goldman Sachs

(0.43)

# 4,399

Out of 5,060 analysts

7

Total ratings

n/a

Success rate

-25.2%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kevin Strang

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	STOK Stoke Therapeutics	Maintained: Buy	$44	$25.32	+73.78%	3	Oct 6, 2026
	PRAX Praxis Precision Medicines	Rated: Buy	$470 → $575	$283.56	+102.78%	4	Aug 21, 2026

Stoke Therapeutics

Oct 6, 2026

Maintained: Buy

Price Target: $44

Current: $25.32

Upside: +73.78%

Praxis Precision Medicines

Aug 21, 2026

Rated: Buy

Price Target: $470 → $575

Current: $283.56

Upside: +102.78%